Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

CANADA,MINISTRY HEALTH

US,CONSUMER PRODUCT SAFETY COMMISSION CANADA,MINISTRY OF HEALTH EUROPEAN COMMISSION... [Pg.100]

Albert. R.E. (1983) The acceptability of using the cancer risk estimates associated with the radiation protection standard of 5 lems/year as the basis for setting protection standards for chemical carcinogens with special reference to vinyl chloride, Report to Ministry of Labor, Occupational Health and Safety Division, Ibronto, Ontetrio, Canada (Ministry of Labor, Occupational Health and Safety Division, Ibronto, Ontario, Canada). [Pg.131]

Health Canada, Ministry of Health. Guidance for Industry Conduct and Analysis of bioavailability and bioequivalence studies. Part A Oral Dosage Formulations Used for Systemic Effects, 1992. [Pg.38]

In Australia, comfrey is classified as a poison, and its sale has been restricted in several states (USP, 1998). In Austria, medicinal preparations of comfrey must be registered with the Federal Ministry of Health and Environmental Protection, and can be sold only in pharmacies. A similar situation exists in Sweden, where comfrey products must be registered. Sale for medicinal use is prohibited in Belgium, the United Kingdom, and Indonesia. In Canada, the Health Protection Branch of Health does not accept comfrey root as an ingredient in medicinal products, and it is listed as unacceptable as a food. In France, as in Germany, the root is permitted for external use only. [Pg.276]

Royal Commission,Report of the Royal Commission on the Health and Safety of Workers in Mines (J.M. Ham, F.R. Hume, C.C. Gray, A.L. Gladstone, J. Beaudry, E.A. Perry, R.P. Riggin, eds), Ministry of the Attorney General, Ontario, Canada (1976). [Pg.443]

Ministry of Health of Canada (2009) Canada Consumer Product Safety Act. Bill C-6. 15.12.2009. http //www.parl.gc.ca/HousePublications/Publication. aspx Docid=3986468 flle=4... [Pg.331]

Relationships are looser in some countries. The health authority of Canada claims that the Canadian GMP guidelines of 2002 [16] have been revised in line with the PIC and the WHO guides as well as the GMP guide on APIs produced by ICH. (See below.) The Japanese Ministry of Health, Labor, and Welfare (MHLW) explains that ordinance no. 3 as the legal base for GMP requirements in Japan [17] has been drawn up taking into account both the relevant paragraphs of the U.S. CFR, parts 210 and 211, as well as the WHO guide. [Pg.859]

The elevated toxaphene levels in Lake Superior have social and economic impacts as well. The 2003 Guide to Eating Sport Fish published by the Ontario Ministry of Environment and Energy [158] indicates fish consumption advisories for Lake Superior lake trout due to toxaphene levels. As a result of the high toxaphene levels, the Ontario Ministry of Natural Resources has restricted sale with Ontario (but not the export) of large lake trout harvested from Lake Superior as of 1995. An assessment of toxaphene levels in Lake Superior fish fillets by Health Canada concluded that consumption of lake trout, salmon, longnose sucker and whitefish muscle from northwestern areas of the lake should be limited to one or two meals per month (55-135 g/week) based on a provisional tolerable daily intake of 0.2 pg/g body wt/day [159]. [Pg.258]

Risk assessment activities of IPCS are supported financially by the Department of Health and Department for Environment, Food Rural Affairs, United Kingdom Environmental Protection Agency, Food and Drug Administration, and National Institute of Environmental Health Sciences, USA European Commission German Federal Ministry of Environment, Nature Conservation and Nuclear Safety Health Canada Japanese Ministry of Health, Labour and Welfare and Swiss Agency for Environment, Forests and Landscape. [Pg.344]

The Testing of Chemicals for Carcinogenicity, Mutagenicity, and Teratogenicity published by the Ministry of National Health and Welfare (Canada)... [Pg.152]

Dupre JS, Mustard JF, Uffen RJ, et al. 1984. Report of the Royal Commission on matters of health and safety arising from the use of asbestos in Ontario. Ontario, Canada Ontario Ministry of the Attorney General, Pubk, 73-112. [Pg.256]

Health Canada is the responsible Ministry for the enforcement of the Food and Drugs Act and for the formulation of and amendments to the Drugs Regulations. The former Drugs Directorate and the Medical Devices Bureau of the Health Protection Branch (HPB) have been combined to form a new agency, the Therapeutic Products Programme (TPP). [Pg.96]

Health Canada, Priority Substances List Assessment Report 2-Butoxyethanol. Draft for Public Comments, Ministry of Public Works and Government Services, Ottawa, August 2000. Available at http //www.hc-sc.gc.ca/hecs-sesc/exsd/psl2.htm (accessed October 2004). [Pg.83]

Chisholm, J., Fish, D., and Tingey, D. 1998. Health professions council recommendation on the designation of traditional Chinese medicine, (updated 2004). Ministry of Health Services. B.C. Canada. http //www.hlth.gov.bc.ca/lg/hpc/reports/apps-tem.htinl/ISS. [Pg.296]

Finkelstein MM. 1989. Mortality among employees of an Ontario factory that manufactured construction materials using chrysotile asbestos and coal tar pitch. Health Studies Service, Ontario Ministry of Labour, Toronto. Canada Am J Ind Med 16(3) 281-287. [Pg.322]

Six founding members of ICH are directly involved in the decision-making process. They represent the regulatory bodies and the industry in the European Union, Japan, and the United States. They are the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) in Europe the Ministry of Health Labor and Welfare and the Japan Pharmaceutical Manufacturers Association (JPMA) in Japan the FDA and the Pharmaceutical Research and Manufacturers of America (PhRMA) and a group of observers including WHO, The European Free Trade Area (EFTA represented at ICH by Swissmedic Switzerland), and Canada represented by Health Canada. [Pg.1385]

Ontario Ministry of Health (2002). Genetics, Testing and Gene Patenting Charting New Territory in Healthcare. Government of Ontario, Toronto, Canada. [Pg.1431]

Currently a number of countries (Australia, Canada, Einland, Norway, UK, The Netherlands) are using pharmaco-economic evaluation, experimentally or definitively, as an additional tool in the decisionmaking process regarding the pricing and reimbursement of medicines one of the most developed of such systems is that applied by the Australian Ministry of Health. [Pg.33]

Health and Welfare Canada. Guidelines for Canadian Drinking Water Quality, Arsenic. Ottawa, Ontario Ministry of Health, 1992. [Pg.109]

The only limits for the intake of uranium by the public are those of Canada and the United States pertaining to the concentration in public water supplies. The Ministry of National Health and Welfare set the Canadian limit at 20 xg/liter (250 mBq/liter) [16]. The current U.S. Environmental Protection Agency limit is 8 p,g/liter (1(X) mBq/liter) and is suggesting an increase to 20 p,g/liter (250 mBq/liter) based on the potential for carcinogenesis [17,18]. [Pg.643]


See other pages where CANADA,MINISTRY HEALTH is mentioned: [Pg.151]    [Pg.884]    [Pg.332]    [Pg.301]    [Pg.1788]    [Pg.3071]    [Pg.34]    [Pg.34]    [Pg.423]    [Pg.231]    [Pg.24]    [Pg.25]    [Pg.26]    [Pg.27]    [Pg.28]    [Pg.31]    [Pg.32]    [Pg.33]    [Pg.465]    [Pg.220]    [Pg.1643]    [Pg.325]    [Pg.347]    [Pg.304]    [Pg.192]   


SEARCH



HEALTH CANADA

© 2024 chempedia.info